Robert B M Landewé Selected Research

Naproxen (Naprosyn)

7/2015	Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
1/2012	Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert B M Landewé Research Topics

Disease

28	Rheumatoid Arthritis 01/2021 - 02/2002
12	Ankylosing Spondylitis 06/2022 - 10/2005
10	Arthritis (Polyarthritis) 01/2022 - 01/2011
7	Axial Spondyloarthritis 01/2022 - 07/2015
7	Pain (Aches) 01/2019 - 01/2012
6	Necrosis 01/2021 - 10/2012
4	COVID-19 01/2022 - 10/2020
4	Cytokine Release Syndrome 04/2021 - 01/2020
3	Uveitis 06/2022 - 01/2011
3	Psoriatic Arthritis 01/2020 - 01/2012
3	Non-Radiographic Axial Spondyloarthritis 12/2019 - 07/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 01/2011
2	Neoplasms (Cancer) 06/2017 - 10/2012
2	Rheumatic Diseases (Rheumatism) 06/2017 - 03/2011
2	Infections 06/2017 - 10/2012
2	Gout 06/2015 - 09/2014
2	Inflammation (Inflammations) 07/2013 - 11/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022
1	Back Pain (Backache) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Fatigue 01/2018
1	Nausea 09/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2013
1	Overweight 10/2013
1	Spondylarthropathies 10/2013
1	Spondylarthritis (Spinal Arthritis) 01/2012
1	Liver Diseases (Liver Disease) 01/2012
1	Osteoarthritis 01/2012
1	Ulcerative Colitis 01/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2011
1	Sarcoidosis (Schaumann Disease) 01/2011
1	Crohn Disease (Crohn's Disease) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2010

Drug/Important Bio-Agent (IBA)

9	GlucocorticoidsIBA 01/2022 - 09/2014
9	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2002
8	Antirheumatic Agents (DMARD)IBA 06/2022 - 04/2013
7	Biological ProductsIBA 01/2020 - 01/2011
6	tocilizumab (atlizumab)FDA Link 04/2021 - 01/2020
6	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 08/2012
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2016 - 01/2012
4	C-Reactive ProteinIBA 01/2022 - 03/2011
3	Adalimumab (Humira)FDA Link 01/2021 - 07/2013
3	Etanercept (Enbrel)FDA Link 01/2021 - 01/2018
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2002
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2020
2	GLPG0634IBA 01/2021 - 01/2020
2	tofacitinibIBA 01/2021 - 01/2020
2	Certolizumab Pegol FDA Link 01/2020 - 01/2018
2	golimumab FDA Link 01/2020 - 10/2012
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2018 - 01/2017
2	amsonic acid (DAS)IBA 09/2017 - 02/2014
2	Naproxen (Naprosyn)FDA LinkGeneric 07/2015 - 01/2012
1	N-phthaloylglutamic acidIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Mono-SIBA 01/2021
1	baricitinibIBA 01/2020
1	upadacitinibIBA 01/2020
1	secukinumabIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	InterleukinsIBA 01/2020
1	sarilumabIBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Janus KinasesIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2019
1	Prostaglandins AIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 06/2015
1	Cyclooxygenase InhibitorsIBA 06/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2014
1	tenoxicamIBA 09/2014
1	Uric Acid (Urate)IBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014
1	AutoantibodiesIBA 10/2013
1	Tramadol (K315)FDA LinkGeneric 01/2012
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2012
1	Opioid Analgesics (Opioids)IBA 01/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2011
1	Immunomodulating AgentsIBA 01/2011
1	Adenosine (Adenocard)FDA LinkGeneric 11/2010
1	human CHI3L1 proteinIBA 09/2010
1	AutoantigensIBA 09/2010
1	GoldIBA 03/2010
1	GadoliniumIBA 10/2005
1	Prednisolone (Predate)FDA LinkGeneric 02/2002

Therapy/Procedure

16	Therapeutics 01/2021 - 02/2002
2	Injections 01/2020 - 02/2014
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Aftercare (After-Treatment) 08/2016
1	Intra-Articular Injections 02/2014
1	Pain Management 01/2012
1	Intranasal Administration 09/2010
1	Immunotherapy 09/2010